0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phentolamine Mesylate Injection Market Research Report 2026
Published Date: 2026-02-04
|
Report Code: QYRE-Auto-10U18665
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Phentolamine Mesylate Injection Market Research Report 2024
BUY CHAPTERS

Global Phentolamine Mesylate Injection Market Research Report 2026

Code: QYRE-Auto-10U18665
Report
2026-02-04
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phentolamine Mesylate Injection Market

The global Phentolamine Mesylate Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Phentolamine Mesylate Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Phentolamine mesylate injection is a formulation of phentolamine, a non-selective alpha-adrenergic antagonist, used primarily for the management of hypertensive episodes, particularly in patients with pheochromocytoma. This injectable preparation allows for rapid administration via intravenous or intramuscular routes, providing quick onset of action in acute situations.
The North American market for Phentolamine Mesylate Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Phentolamine Mesylate Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Phentolamine Mesylate Injection include Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Phentolamine Mesylate Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Phentolamine Mesylate Injection. The Phentolamine Mesylate Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Phentolamine Mesylate Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Phentolamine Mesylate Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Phentolamine Mesylate Injection Market Report

Report Metric Details
Report Name Phentolamine Mesylate Injection Market
Segment by Type
  • Intravenous Injection
  • Intramuscular Injection
by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Phentolamine Mesylate Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Phentolamine Mesylate Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Phentolamine Mesylate Injection Market report?

Ans: The main players in the Phentolamine Mesylate Injection Market are Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm

What are the Application segmentation covered in the Phentolamine Mesylate Injection Market report?

Ans: The Applications covered in the Phentolamine Mesylate Injection Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Phentolamine Mesylate Injection Market report?

Ans: The Types covered in the Phentolamine Mesylate Injection Market report are Intravenous Injection, Intramuscular Injection

1 Phentolamine Mesylate Injection Market Overview
1.1 Product Definition
1.2 Phentolamine Mesylate Injection by Type
1.2.1 Global Phentolamine Mesylate Injection Market Value by Type: 2025 vs 2032
1.2.2 Intravenous Injection
1.2.3 Intramuscular Injection
1.3 Phentolamine Mesylate Injection by Application
1.3.1 Global Phentolamine Mesylate Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Phentolamine Mesylate Injection Market Size Estimates and Forecasts
1.4.1 Global Phentolamine Mesylate Injection Revenue 2021–2032
1.4.2 Global Phentolamine Mesylate Injection Sales 2021–2032
1.4.3 Global Phentolamine Mesylate Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Phentolamine Mesylate Injection Market Competition by Manufacturers
2.1 Global Phentolamine Mesylate Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Phentolamine Mesylate Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Phentolamine Mesylate Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Phentolamine Mesylate Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Phentolamine Mesylate Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Phentolamine Mesylate Injection, Product Types and Applications
2.7 Global Key Manufacturers of Phentolamine Mesylate Injection, Date of Entry into the Industry
2.8 Global Phentolamine Mesylate Injection Market Competitive Situation and Trends
2.8.1 Global Phentolamine Mesylate Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Phentolamine Mesylate Injection Players Market Share by Revenue
2.8.3 Global Phentolamine Mesylate Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Phentolamine Mesylate Injection Market Scenario by Region
3.1 Global Phentolamine Mesylate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Phentolamine Mesylate Injection Sales by Region: 2021–2032
3.2.1 Global Phentolamine Mesylate Injection Sales by Region: 2021–2026
3.2.2 Global Phentolamine Mesylate Injection Sales by Region: 2027–2032
3.3 Global Phentolamine Mesylate Injection Revenue by Region: 2021–2032
3.3.1 Global Phentolamine Mesylate Injection Revenue by Region: 2021–2026
3.3.2 Global Phentolamine Mesylate Injection Revenue by Region: 2027–2032
3.4 North America Phentolamine Mesylate Injection Market Facts & Figures by Country
3.4.1 North America Phentolamine Mesylate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Phentolamine Mesylate Injection Sales by Country (2021–2032)
3.4.3 North America Phentolamine Mesylate Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Phentolamine Mesylate Injection Market Facts & Figures by Country
3.5.1 Europe Phentolamine Mesylate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Phentolamine Mesylate Injection Sales by Country (2021–2032)
3.5.3 Europe Phentolamine Mesylate Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phentolamine Mesylate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Phentolamine Mesylate Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Phentolamine Mesylate Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Phentolamine Mesylate Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Phentolamine Mesylate Injection Market Facts & Figures by Country
3.7.1 Latin America Phentolamine Mesylate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Phentolamine Mesylate Injection Sales by Country (2021–2032)
3.7.3 Latin America Phentolamine Mesylate Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Phentolamine Mesylate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Phentolamine Mesylate Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Phentolamine Mesylate Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Phentolamine Mesylate Injection Sales by Type (2021–2032)
4.1.1 Global Phentolamine Mesylate Injection Sales by Type (2021–2026)
4.1.2 Global Phentolamine Mesylate Injection Sales by Type (2027–2032)
4.1.3 Global Phentolamine Mesylate Injection Sales Market Share by Type (2021–2032)
4.2 Global Phentolamine Mesylate Injection Revenue by Type (2021–2032)
4.2.1 Global Phentolamine Mesylate Injection Revenue by Type (2021–2026)
4.2.2 Global Phentolamine Mesylate Injection Revenue by Type (2027–2032)
4.2.3 Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021–2032)
4.3 Global Phentolamine Mesylate Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Phentolamine Mesylate Injection Sales by Application (2021–2032)
5.1.1 Global Phentolamine Mesylate Injection Sales by Application (2021–2026)
5.1.2 Global Phentolamine Mesylate Injection Sales by Application (2027–2032)
5.1.3 Global Phentolamine Mesylate Injection Sales Market Share by Application (2021–2032)
5.2 Global Phentolamine Mesylate Injection Revenue by Application (2021–2032)
5.2.1 Global Phentolamine Mesylate Injection Revenue by Application (2021–2026)
5.2.2 Global Phentolamine Mesylate Injection Revenue by Application (2027–2032)
5.2.3 Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021–2032)
5.3 Global Phentolamine Mesylate Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Septodont
6.1.1 Septodont Company Information
6.1.2 Septodont Description and Business Overview
6.1.3 Septodont Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Septodont Phentolamine Mesylate Injection Product Portfolio
6.1.5 Septodont Recent Developments/Updates
6.2 Hikma
6.2.1 Hikma Company Information
6.2.2 Hikma Description and Business Overview
6.2.3 Hikma Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hikma Phentolamine Mesylate Injection Product Portfolio
6.2.5 Hikma Recent Developments/Updates
6.3 Precision Dose
6.3.1 Precision Dose Company Information
6.3.2 Precision Dose Description and Business Overview
6.3.3 Precision Dose Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Precision Dose Phentolamine Mesylate Injection Product Portfolio
6.3.5 Precision Dose Recent Developments/Updates
6.4 CR Double-Crane
6.4.1 CR Double-Crane Company Information
6.4.2 CR Double-Crane Description and Business Overview
6.4.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CR Double-Crane Phentolamine Mesylate Injection Product Portfolio
6.4.5 CR Double-Crane Recent Developments/Updates
6.5 Sichuan Meida Kangjiale Pharmaceutical
6.5.1 Sichuan Meida Kangjiale Pharmaceutical Company Information
6.5.2 Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview
6.5.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
6.5.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates
6.6 Sunflower Pharmaceutical
6.6.1 Sunflower Pharmaceutical Company Information
6.6.2 Sunflower Pharmaceutical Description and Business Overview
6.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio
6.6.5 Sunflower Pharmaceutical Recent Developments/Updates
6.7 Shanghai Fudan Forward Pharmaceuticals
6.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information
6.7.2 Shanghai Fudan Forward Pharmaceuticals Description and Business Overview
6.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio
6.7.5 Shanghai Fudan Forward Pharmaceuticals Recent Developments/Updates
6.8 Hainan Poly Pharm
6.8.1 Hainan Poly Pharm Company Information
6.8.2 Hainan Poly Pharm Description and Business Overview
6.8.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio
6.8.5 Hainan Poly Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phentolamine Mesylate Injection Industry Chain Analysis
7.2 Phentolamine Mesylate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phentolamine Mesylate Injection Production Mode & Process Analysis
7.4 Phentolamine Mesylate Injection Sales and Marketing
7.4.1 Phentolamine Mesylate Injection Sales Channels
7.4.2 Phentolamine Mesylate Injection Distributors
7.5 Phentolamine Mesylate Injection Customer Analysis
8 Phentolamine Mesylate Injection Market Dynamics
8.1 Phentolamine Mesylate Injection Industry Trends
8.2 Phentolamine Mesylate Injection Market Drivers
8.3 Phentolamine Mesylate Injection Market Challenges
8.4 Phentolamine Mesylate Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Phentolamine Mesylate Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Phentolamine Mesylate Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Phentolamine Mesylate Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Phentolamine Mesylate Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Phentolamine Mesylate Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Phentolamine Mesylate Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Phentolamine Mesylate Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Phentolamine Mesylate Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Phentolamine Mesylate Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Phentolamine Mesylate Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Phentolamine Mesylate Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Phentolamine Mesylate Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Phentolamine Mesylate Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Phentolamine Mesylate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Phentolamine Mesylate Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Phentolamine Mesylate Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Phentolamine Mesylate Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Phentolamine Mesylate Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Phentolamine Mesylate Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Phentolamine Mesylate Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Phentolamine Mesylate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Phentolamine Mesylate Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Phentolamine Mesylate Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Phentolamine Mesylate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Phentolamine Mesylate Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Phentolamine Mesylate Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Phentolamine Mesylate Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Phentolamine Mesylate Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Phentolamine Mesylate Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Phentolamine Mesylate Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Phentolamine Mesylate Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Phentolamine Mesylate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Phentolamine Mesylate Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Phentolamine Mesylate Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Phentolamine Mesylate Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Phentolamine Mesylate Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Phentolamine Mesylate Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Phentolamine Mesylate Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Phentolamine Mesylate Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Phentolamine Mesylate Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Phentolamine Mesylate Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Phentolamine Mesylate Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Phentolamine Mesylate Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Phentolamine Mesylate Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Septodont Company Information
 Table 71. Septodont Description and Business Overview
 Table 72. Septodont Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Septodont Phentolamine Mesylate Injection Product
 Table 74. Septodont Recent Developments/Updates
 Table 75. Hikma Company Information
 Table 76. Hikma Description and Business Overview
 Table 77. Hikma Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Hikma Phentolamine Mesylate Injection Product
 Table 79. Hikma Recent Developments/Updates
 Table 80. Precision Dose Company Information
 Table 81. Precision Dose Description and Business Overview
 Table 82. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Precision Dose Phentolamine Mesylate Injection Product
 Table 84. Precision Dose Recent Developments/Updates
 Table 85. CR Double-Crane Company Information
 Table 86. CR Double-Crane Description and Business Overview
 Table 87. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. CR Double-Crane Phentolamine Mesylate Injection Product
 Table 89. CR Double-Crane Recent Developments/Updates
 Table 90. Sichuan Meida Kangjiale Pharmaceutical Company Information
 Table 91. Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview
 Table 92. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product
 Table 94. Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates
 Table 95. Sunflower Pharmaceutical Company Information
 Table 96. Sunflower Pharmaceutical Description and Business Overview
 Table 97. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product
 Table 99. Sunflower Pharmaceutical Recent Developments/Updates
 Table 100. Shanghai Fudan Forward Pharmaceuticals Company Information
 Table 101. Shanghai Fudan Forward Pharmaceuticals Description and Business Overview
 Table 102. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product
 Table 104. Shanghai Fudan Forward Pharmaceuticals Recent Developments/Updates
 Table 105. Hainan Poly Pharm Company Information
 Table 106. Hainan Poly Pharm Description and Business Overview
 Table 107. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Hainan Poly Pharm Phentolamine Mesylate Injection Product
 Table 109. Hainan Poly Pharm Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Phentolamine Mesylate Injection Distributors List
 Table 113. Phentolamine Mesylate Injection Customers List
 Table 114. Phentolamine Mesylate Injection Market Trends
 Table 115. Phentolamine Mesylate Injection Market Drivers
 Table 116. Phentolamine Mesylate Injection Market Challenges
 Table 117. Phentolamine Mesylate Injection Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Phentolamine Mesylate Injection
 Figure 2. Global Phentolamine Mesylate Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Phentolamine Mesylate Injection Market Share by Type: 2025 & 2032
 Figure 4. Intravenous Injection Product Picture
 Figure 5. Intramuscular Injection Product Picture
 Figure 6. Global Phentolamine Mesylate Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Phentolamine Mesylate Injection Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinic
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Phentolamine Mesylate Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Phentolamine Mesylate Injection Market Size (US$ Million), 2021–2032
 Figure 13. Global Phentolamine Mesylate Injection Sales (K Units), 2021–2032
 Figure 14. Global Phentolamine Mesylate Injection Average Price (US$/Unit), 2021–2032
 Figure 15. Phentolamine Mesylate Injection Report Years Considered
 Figure 16. Phentolamine Mesylate Injection Sales Share by Manufacturers in 2025
 Figure 17. Global Phentolamine Mesylate Injection Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Phentolamine Mesylate Injection Players: Market Share by Revenue in Phentolamine Mesylate Injection in 2025
 Figure 19. Phentolamine Mesylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Phentolamine Mesylate Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Phentolamine Mesylate Injection Sales Market Share by Country (2021–2032)
 Figure 22. North America Phentolamine Mesylate Injection Revenue Market Share by Country (2021–2032)
 Figure 23. United States Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Phentolamine Mesylate Injection Sales Market Share by Country (2021–2032)
 Figure 26. Europe Phentolamine Mesylate Injection Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Phentolamine Mesylate Injection Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Phentolamine Mesylate Injection Revenue Market Share by Region (2021–2032)
 Figure 34. China Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Phentolamine Mesylate Injection Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Phentolamine Mesylate Injection Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Phentolamine Mesylate Injection Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Phentolamine Mesylate Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Phentolamine Mesylate Injection by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Phentolamine Mesylate Injection by Type (2021–2032)
 Figure 54. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Phentolamine Mesylate Injection by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Phentolamine Mesylate Injection by Application (2021–2032)
 Figure 57. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2021–2032)
 Figure 58. Phentolamine Mesylate Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools